Description

Kisqali 200mg Tablet (Ribociclib) – China Imported – Uses, Side Effects, Dosage & Price in Pakistan

Kisqali 200mg Tablet (Ribociclib) – China Imported is a prescription targeted cancer medicine containing ribociclib 200mg. Ribociclib belongs to a group of medicines known as CDK4/6 inhibitors (cyclin-dependent kinase inhibitors). It is primarily used as part of combination treatment for certain HR-positive, HER2-negative breast cancers.

Kisqali works differently from traditional chemotherapy. It targets specific proteins involved in cancer-cell division and is normally combined with appropriate endocrine or hormonal therapy. The exact treatment combination depends on the stage of breast cancer, previous treatment and individual patient factors.

Patients searching for Kisqali 200mg Tablet price in Pakistan should remember that imported medicine prices and availability can change. Impo Medic can provide product and availability information for patients in Pakistan, while treatment should remain under an oncologist’s supervision.

Kisqali 200mg Tablet (Ribociclib) Used

Kisqali is used for specific forms of HR-positive and HER2-negative breast cancer.

According to current prescribing information, Kisqali may be prescribed in combination with an aromatase inhibitor as adjuvant treatment for adults with HR-positive, HER2-negative stage II or III early breast cancer at high risk of recurrence.

It is also used for adults with HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant, depending on the treatment setting.

Kisqali is therefore not appropriate for every breast cancer patient. Hormone-receptor and HER2 test results are important in determining whether this medicine is suitable.

How Does Kisqali Work?

Ribociclib blocks CDK4 and CDK6, two proteins that help regulate cell division.

In HR-positive breast cancer, these proteins can contribute to cancer-cell growth. By inhibiting CDK4/6 activity, ribociclib can slow progression through the cell cycle and reduce the ability of susceptible cancer cells to multiply.

Kisqali is used together with endocrine therapy because the treatments act on different pathways involved in hormone-sensitive breast cancer.

Kisqali 200mg Tablet Dosage

It is important to understand that 200mg is the strength of each Kisqali tablet, not necessarily the complete daily treatment dose.

For early breast cancer, current prescribing information gives a recommended Kisqali starting dose of 400mg once daily for 21 consecutive days, followed by 7 days without Kisqali, forming a 28-day cycle. This corresponds to two 200mg tablets per treatment day.

For advanced or metastatic breast cancer, the recommended starting dose is generally 600mg once daily for 21 consecutive days followed by 7 days off, corresponding to three 200mg tablets per treatment day.

Dose reductions, treatment interruptions or discontinuation may be required depending on side effects, laboratory results, drug interactions, kidney/liver function and individual tolerability.

Patients should never calculate or change their own Kisqali dose.

How to Take Kisqali 200mg Tablet

Kisqali can be taken with or without food. It should generally be taken at approximately the same time each day, preferably in the morning.

Tablets should be swallowed whole and should not be crushed, chewed or split.

If a patient vomits after taking a dose or forgets a scheduled dose, an additional dose should not be taken that day. The next prescribed dose should be taken at the usual time.

Always follow the schedule provided by your oncology team.

Common Side Effects of Kisqali

Like other cancer medicines, Kisqali can cause side effects. Their severity differs between patients and may also depend on the other medicine being taken with ribociclib.

Possible side effects can include:

• Reduced white blood cell counts
• Nausea
• Tiredness
• Headache
• Diarrhea
• Constipation
• Hair thinning or hair loss
• Reduced appetite
• Skin rash
• Abnormal liver test results

Regular medical monitoring is an important part of Kisqali treatment.

Serious Warnings and Precautions

Low White Blood Cell Counts

Ribociclib can significantly lower neutrophils, a type of white blood cell involved in fighting infections.

Blood counts therefore need to be monitored during treatment.

Patients should promptly tell their healthcare team about fever, chills or other signs of infection.

Liver Problems

Kisqali can affect liver function. Doctors normally perform liver blood tests before and during therapy.

Contact your healthcare provider if you develop symptoms such as yellowing of the skin or eyes, unusually dark urine, severe tiredness or significant upper abdominal discomfort.

Heart Rhythm Changes

Ribociclib can cause QT interval prolongation, which affects the electrical activity of the heart.

Patients may require an ECG and electrolyte monitoring before and during treatment. Certain medicines that also prolong the QT interval should be avoided unless specifically reviewed by the treating doctor.

Lung Problems

CDK4/6 inhibitors, including Kisqali, have been associated with interstitial lung disease (ILD) and pneumonitis, which can occasionally become severe.

New or worsening shortness of breath, cough or difficulty breathing should be reported promptly.

Monitoring During Kisqali Treatment

Patients receiving Kisqali 200mg Tablet (Ribociclib) may require regular monitoring.

Depending on the treatment stage, this can include:

• Complete blood count
• Liver-function tests
• ECG monitoring
• Blood electrolyte levels
• Assessment for infection
• Assessment for lung symptoms
• Monitoring of treatment response

Do not skip oncology appointments simply because you feel well.

Drug and Food Interactions

Ribociclib is involved in clinically important interactions with medicines that affect the CYP3A pathway.

Strong CYP3A inhibitors can increase ribociclib exposure, while strong CYP3A inducers can reduce its effectiveness. Current prescribing information recommends avoiding certain strong CYP3A inhibitors and inducers.

Patients should give their oncologist a complete list of prescription medicines, non-prescription products, vitamins and herbal supplements before starting treatment.

Avoid introducing new medicines or supplements without discussing them with the oncology team.

Pregnancy and Breastfeeding

Ribociclib may cause harm to an unborn baby. Patients who can become pregnant should discuss effective contraception with their healthcare provider before and during treatment.

Breastfeeding is not recommended during ribociclib treatment according to current prescribing information.

Patients planning pregnancy should discuss this with their oncologist before treatment.

Kisqali 200mg Tablet Price in Pakistan

The Kisqali 200mg Tablet price in Pakistan can vary because of pack size, import source, exchange rates, supplier availability and market conditions.

For a China Imported Kisqali 200mg Tablet, availability and price can change more frequently than locally distributed medicines.

Instead of relying on an outdated fixed price, patients can contact Impo Medic to check current product and availability information in Pakistan.

Always confirm the exact product strength, pack size and manufacturer details before obtaining an imported medicine.

Kisqali 200mg Tablet Availability in Pakistan

Availability of Kisqali 200mg Tablet (Ribociclib) – China Imported may vary across Pakistan because ribociclib is a specialist oncology medicine.

Patients searching for Kisqali in Pakistan should confirm:

• Ribociclib 200mg strength
• Manufacturer
• Pack size
• Import source
• Expiry date
• Storage condition
• Packaging integrity

Impo Medic can assist with product and availability information for patients looking for imported and specialty medicines in Pakistan.

How to Buy Kisqali 200mg Tablet in Pakistan

Patients looking for Kisqali 200mg Tablet in Pakistan can contact Impo Medic for current availability and product information.

Because Kisqali is a prescription cancer medicine, it should only be obtained through legitimate medicine-supply channels and used under the supervision of a qualified oncologist.

Do not start ribociclib simply because the medicine is available. Your cancer type, hormone-receptor status, HER2 status, current medicines and medical history need to be considered by your oncology team.

Why Choose Impo Medic?

Impo Medic focuses on helping patients in Pakistan find information about imported, specialty and oncology medicines.

For products such as Kisqali 200mg Tablet (Ribociclib) – China Imported, patients can contact Impo Medic to check current availability and product details.

Our goal is to provide clear medicine information while encouraging safe, prescription-based use. Cancer medicines should always be used according to an oncologist’s treatment plan.

Storage Instructions

Keep Kisqali in its original packaging and follow the storage instructions printed on the supplied pack.

General precautions include:

• Keep away from children.
• Protect the medicine from inappropriate heat and moisture.
• Do not use damaged tablets.
• Check the expiry date before use.
• Keep tablets in their original packaging until required.

For imported products, check that the packaging is intact before use.

Frequently Asked Questions

What is Kisqali 200mg Tablet (Ribociclib) used for?

Kisqali is used in combination with endocrine therapy for certain adults with HR-positive, HER2-negative breast cancer, including specified early and advanced/metastatic settings.

What is the active ingredient in Kisqali 200mg?

The active ingredient is ribociclib, and each tablet contains 200mg of ribociclib.

Is Kisqali chemotherapy?

Kisqali is generally classified as a targeted cancer treatment, specifically a CDK4/6 inhibitor, rather than conventional cytotoxic chemotherapy.

Is Kisqali 200mg the normal daily dose?

Not necessarily. The 200mg figure describes the strength of one tablet. Depending on the indication, current recommended starting regimens can involve 400mg or 600mg per treatment day, followed by the scheduled treatment break. Dose modifications may also be necessary.

Can Kisqali be taken with food?

Yes. Kisqali can be taken with or without food and should generally be taken at approximately the same time each day.

What are the major side effects of Kisqali?

Important concerns include reduced white blood cell counts, liver toxicity, QT prolongation and ILD/pneumonitis. Patients require regular monitoring during treatment.

What is Kisqali 200mg Tablet price in Pakistan?

The price varies depending on pack size, import source, exchange rate and availability. Contact Impo Medic for current product and availability information rather than relying on an outdated fixed price.

Where can I find China Imported Kisqali 200mg in Pakistan?

Availability can vary. Patients may contact Impo Medic for information about Kisqali 200mg Tablet (Ribociclib) – China Imported while following their oncologist’s prescription and applicable medicine-supply requirements.